Companies / Lucira Health, Inc.
Lucira Health, Inc.
LHDXCIK 1652724
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 5, 2021 | EPIQ Capital Group, LLC 10% owner | Buy Open-market buy | Common Stock | $58.85M | +3.5M | 3,461,764 | high |
| Feb 5, 2021 | EPIQ Capital Group, LLC 10% owner | Other Derivative conversion | Common Stock | $12.50M | +735K | 735,475 | low |
| Feb 9, 2021 | Eclipse GP III, LLC 10% owner | Other Derivative conversion | Common Stock | $6.44M | +474K +12.77% | 4,183,986 | low |
| Feb 9, 2021 | Susan Lior Director | Other Derivative conversion | Common Stock | $6.44M | +474K +12.77% | 4,183,986 | low |
| Feb 9, 2021 | Yen Tuff Director | Other Derivative conversion | Common Stock | $1.02M | +75K +6.47% | 1,228,195 | low |
| Feb 9, 2021 | Yen Tuff Director | Other Derivative conversion | Common Stock | $837.6K | +62K +6.47% | 1,013,473 | low |
| Mar 3, 2023 | Engelson Erik T. CEO | Sell Open-market sale | Common Stock | $591.9K | -575K -87.34% | 83,282 | medium |
| Mar 3, 2023 | Engelson Erik T. CEO | Exercise Option exercise | Common Stock | $471.2K | +575K +690.02% | 657,948 | low |